TSHA
#2286
Taysha Gene Therapies, Inc. - Common Stock
3.5 8 USD
-0.14%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-13.53%
Variación mensual
-29.67%
Variación en los últimos 6 meses
-24.31%
Cambio anual
-32.96%
Cierres anteriores
4.1 4
Open
4.0 9
Mínimo
3.5 5
Máximo
4.1 3
Financials
- Market Capitalization 1.17 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-16.18
Relación precio/flujo de caja
179.93
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2282 |  ORIC Oric Pharmaceuticals, Inc. - Common Stock | 11.31 USD | -4.23% | -4.40% | -10.24% | -16.28% | 1.17 B USD | ||
| 2284 |  GHRS GH Research PLC - Ordinary Shares | 18.85 USD | -5.84% | -11.87% | -31.78% | +33.12% | 1.17 B USD | ||
| 2298 |  BCAX Bicara Therapeutics Inc. - Common Stock | 17.34 USD | +0.06% | +5.47% | -24.97% | +20.08% | 1.15 B USD | ||
| 2303 |  REPL Replimune Group, Inc. - Common Stock | 12.11 USD | -7.35% | -7.84% | -6.70% | +177.75% | 1.14 B USD |